Your browser doesn't support javascript.
A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
Hussain, Nabeel; Agarwala, Preeti; Iqbal, Kinza; Omar, Hanaa Mohamed Sheikh; Jangid, Gurusha; Patel, Vraj; Rathore, Sawai Singh; Kumari, Chandani; Velasquez-Botero, Felipe; López, Guadalupe Abigail Benítez; Vishwakarma, Yogesh; Nipu, Airin Parvin; Ahmed, Noman Khurshid.
  • Hussain N; Saba University School of Medicine, The Bottom, The Netherlands.
  • Agarwala P; Rajshahi Medical College and Hospital, Rajshahi, Bangladesh.
  • Iqbal K; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
  • Omar HMS; Zamzam University of Science & Technology, Mogadishu, Somalia.
  • Jangid G; Dr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.
  • Patel V; Smt NHL Municipal Medical College, Ahmedabad, Gujarat, India.
  • Rathore SS; Dr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.
  • Kumari C; American University of Barbados, Wildey, St. Michael, Barbados.
  • Velasquez-Botero F; Universidad CES, Medellin, Colombia.
  • López GAB; Larkin Community Hospital, Miami, Florida, USA.
  • Vishwakarma Y; Larkin Community Hospital, Miami, Florida, USA.
  • Nipu AP; American University of Barbados, Wildey, St. Michael, Barbados.
  • Ahmed NK; University of Arkansas at Pine Bluff, Pine Bluff, Arkansas, USA.
J Med Virol ; 94(4): 1391-1401, 2022 04.
Article in English | MEDLINE | ID: covidwho-1718412
ABSTRACT
This systematic review focuses on the clinical features, physical examination findings, outcomes, and underlying pathology of acute telogen effluvium (TE), a type of diffuse hair loss, occurring in coronavirus disease 2019 (COVID-19) recovered patients. MEDLINE/PubMed and Embase databases were queried till October 2021 to identify studies reporting acute TE occurring after COVID-19 recovery. Data were obtained from 19 studies, which included 465 patients who were diagnosed with acute TE. The median age of these patients was 44 years and 67.5% were females. The most common trichoscopic findings were decreased hair density, the presence of empty follicles, or short regrowing hair. The mean duration from COVID-19 symptom onset to the appearance of acute TE was 74 days, which is earlier than classic acute TE. Most patients recovered from hair loss, while a few patients had persistent hair fall. Our results highlight the need to consider the possibility of post-COVID-19 acute TE in patients presenting with hair fall, with a history of COVID-19 infection, in the context of COVID-19 pandemic. Despite being a self-limiting condition, hair loss post-COVID-19 is a stressful manifestation. Identifying COVID-19 infection as a potential cause of acute TE will help the clinicians counsel the patients, relieving them from undue stress.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alopecia Areata / COVID-19 Type of study: Diagnostic study / Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27534

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Alopecia Areata / COVID-19 Type of study: Diagnostic study / Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27534